Icariside II ameliorates diabetic nephropathy in streptozotocin-induced diabetic rats

PURPOSE: To investigate the therapeutic effects and potential mechanisms of icariside II (ICA II) on reversing diabetic nephropathy in streptozotocin (STZ)-induced type I diabetic rats. METHODS: Newborn male Sprague Dawley rats were labeled with thymidine analog 5-ethynyl-2-deoxyuridine (EdU) for tr...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Drug Des Devel Ther
Hlavní autoři: Tian, Wenjie, Lei, Hongen, Guan, Ruili, Xu, Yongde, Li, Huixi, Wang, Lin, Yang, Bicheng, Gao, Zhezhu, Xin, Zhongcheng
Médium: Artigo
Jazyk:Inglês
Vydáno: Dove Medical Press 2015
Témata:
Original Research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4567177/
https://ncbi.nlm.nih.gov/pubmed/26379427
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DDDT.S90060
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky